Cleared Traditional

PACIFIC HEMOSTASIS IMMUNODEPLETED FACTOR V DEFICIENT PLASMA (THROMBOSDREEN BRAND) (100056)

K972627 · Pacific Hemostasis · Hematology
Aug 1997
Decision
30d
Days
Class 2
Risk

About This 510(k) Submission

K972627 is an FDA 510(k) clearance for the PACIFIC HEMOSTASIS IMMUNODEPLETED FACTOR V DEFICIENT PLASMA (THROMBOSDREEN BRAND) (100056), a Plasma, Coagulation Factor Deficient (Class II — Special Controls, product code GJT), submitted by Pacific Hemostasis (Huntersville, US). The FDA issued a Cleared decision on August 13, 1997, 30 days after receiving the submission on July 14, 1997. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7290.

Submission Details

510(k) Number K972627 FDA.gov
FDA Decision Cleared SESE
Date Received July 14, 1997
Decision Date August 13, 1997
Days to Decision 30 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GJT — Plasma, Coagulation Factor Deficient
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.7290

Similar Devices — GJT Plasma, Coagulation Factor Deficient

All 78
CRYOcheck Factor VIII Deficient Plasma with VWF
K222831 · Precision Biologic, Inc. · Sep 2023
HemosIL Factor XII Deficient Plasma
K180486 · Instrumentation Laboratory CO · Mar 2018
NOFACT VIII
K102851 · R2 Diagnostics, Inc. · Dec 2011
NOFACT IX
K102908 · R2 Diagnostics, Inc. · Dec 2011
HEMOSIL FACTOR VIII DEFICIENT PLASMA
K110237 · Instrumentation Laboratory CO · Jul 2011
HEMOSIL FACTOR II DEFICIENT PLASMA
K050661 · Instrumentation Laboratory CO · May 2005